Practice Change Needed for Gastroesophageal Cancer?

(MedPage Today) -- Treatment with pembrolizumab (Keytruda) improved survival for patients with microsatellite instability-high (MSI-H) gastric or gastroesophageal junction (GEJ) cancer, irrespective of the number of prior therapies, a retrospective...